Becker's Healthcare September 30, 2022
Rylee Wilson

The first drugs negotiated by Medicare are likely to be blood thinners, diabetes treatments and cancer drugs, physicians predicted in a Sept. 30 article for Health Affairs.

Medicare will begin negotiating prices for certain drugs as part of the Inflation Reduction Act. These changesbegin rolling out in 2023, with the agency negotiating prices for 10 drugs, which are set to go into effect in 2026.

Certain criteria dictate which drugs Medicare can negotiate for — drugs must have been on the market for at least seven years, or 11 years for biologics. These drugs also must be single-source, with no generics available.

Based on these criteria, Micah Johnson, MD, Rahul Nayak, MD, and Sanjay Kishore, MD, predicted which...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech
Understanding the politics of drug pricing in the United States
HHS Announces Medicaid and Medicare Flexibilities, Investigations post-Change Healthcare Cyberattack
Medicare, Medicaid made $100B in improper payments in 2023
Medicare’s GLP-1 spending is skyrocketing, even without weight loss coverage: KFF
Can Hospital At Home Finally Hit Its Tipping Point? Lessons From The Hospitalist Field

Share This Article